The Impact of Erythropoietin on Short and Long-term Kidney-Related Outcomes in Extremely Low Gestational Age Neonates. Results of a Multi-center Double-Blind Placebo-Controlled Randomized Clinical Trial

OBJECTIVE: To evaluate whether extremely low gestational age neonates (ELGANs) randomized to erythropoietin have better or worse kidney-related outcomes during hospitalization and at 22–26 months corrected gestational age (cGA) compared with those randomized to placebo. STUDY DESIGN: We performed an...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pediatr
Hlavní autoři: Askenazi, David J., Heagerty, Patrick J., Schmicker, Robert H., Brophy, Patrick, Juul, Sandra E., Goldstein, Stuart L., Hingorani, Sangeeta
Médium: Artigo
Jazyk:Inglês
Vydáno: 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8093092/
https://ncbi.nlm.nih.gov/pubmed/33484699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2021.01.031
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky